Combined cardiorenal transplant in heart and advanced renal disease

  • Margarita Peradejordi Lastras División Trasplante Intratorácico e Insuficiencia Cardíaca, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Liliana Ethel Favaloro División Trasplante Intratorácico e Insuficiencia Cardíaca, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Rita Marcela Fortunato Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Luis Gutiérrez Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Gabriel Eduardo Rabin Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Daniel Oscar Absi División Trasplante Intratorácico e Insuficiencia Cardíaca, Hospital Universitario Fundación Favaloro, Buenos Aires
  • José Abud División Trasplante Intratorácico e Insuficiencia Cardíaca, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Héctor Raffaelli Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Rodolfo Marrugat Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Hugo Fraguas Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Roberto René Favaloro División Trasplante Intratorácico e Insuficiencia Cardíaca, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Pablo Raffaele Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
  • Alejandro Mario Bertolotti División Trasplante Intratorácico e Insuficiencia Cardíaca, Hospital Universitario Fundación Favaloro, Buenos Aires
Keywords: cardiac transplant, renal transplant, cardiorenal transplant, combined transplant, renal failure

Abstract

Introduction: Renal failure (RF) is a post cardiac transplantation predictor of morbimortality. The combined cardiorenal transplant (CCRTx) in cardiac transplantation (CTx) candidates with chronic renal disease is a therapeutic option. Our aim was to evaluate the CCRTx follow up outcomes in a single Centre. Methods: Between 2/1993 and 12/2014 we performed 442 CTx. Since 2006, 20 patients (p) underwent CCRTx using allografts from the same donor. The inclusion criteria were: RF with CrCl ≤ 40 mil/min or dialysis requirement in CTx candidates. All p received Thymoglobulin and immunosuppression with tacrolimus, mycophenolate mofetil and steroids.Median follow up: 46 months (7-96). Results: Mean age: 58±7 years, 85% were male. Mean Creatinine (Cr): 3,1±2,5 mg/dl and ClCr 27,5+10 mil/min. Three p required dialysis during the pre-transplantation phase and 4 p were under chronic dialysis. Etiologies: cardiomyopathies: coronary 10 p, noncoronary 9 p and re CTx, 1 p; nephropathies: nephroangiosclerosis 5 p, cardiorenal syndrome 10 p, diabetes 2 p, glomerulopathy 1 p, polycystosis 1 p and toxic nephritis 1 p. At 30 days and 1 year post CCRTx, Cr was 1,2±0,4 mg/dl and 1,1±0,2 mg/dl respectively. In-hospital mortality was 3/20 p (15%), 2 p due to sepsis and 1 p due to cardiac graft failure. Late mortality 5/17 p (29 %), 4p due to sepsis and 1 p due to liver sarcoma. Survival at 1 and 3 years was 76 and 72%, respectively. Conclusions: In our series CCRTx was a safe and effective treatment for CTx candidates with CrCl < 40 ml/min.

Author Biography

Luis Gutiérrez, Unidad Renal, Hospital Universitario Fundación Favaloro, Buenos Aires
Los autores declaran no poseer ningún interés comercial o asociativo que presente un conflicto de intereses con el
trabajo presentado.

References

McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109(8):1004-9.

Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35(3):681-9.

Shamagian L, Varela RA, Pedreira Pérez M , Gómez Otero I, Virgós Lamela A, González-Juanatey JR. La insuficiencia renal es un predictor independiente de la mortalidad en pacientes hospitalizados por insuficiencia cardíaca y se asocia con un peor perfil de riesgo cardiovascular. Rev Esp Cardiol. 2006;59(2):99-108.

Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J. 2008;29(8):1029-36.

Abbott KC, Bakris GL. Cardiology patient page. Kidney failure and cardiovascular disease. Circulation. 2003;108(16):e114-5.

De Zeeuw D. Renal disease: a common and a silent killer. Nat Clin Pract Cardiovasc Med. 2008 Jul;5 Suppl 1:S27-35.

Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant. 2010;29(10):1089-103.

Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B. The natural history of renal function following orthotopic heart transplant. Clin Transplant. 2005;19(5):683-9.

Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: eighth

official pediatric report-2005. J Heart Lung Transplant. 2005;24(8):968-82.

Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25(9):1024-42.

Bruschi G, Busnach G, Colombo T, Radaelli L, Pedrazzini G, Garatti A, et al. Long-term follow-up of simultaneous heart and kidney transplantation with single donor allografts: report of nine cases. Ann Thorac Surg. 2007;84(2):522-7.

Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931-40.

Favaloro LE, Peradejordi Lastras M, Favaloro RR. Trasplante cardíaco. En: Mautner B. Cardiología. Basada en la evidencia y la experiencia de la Fundación Favaloro. 2a ed. Santiago de Chile: Mediterráneo, 2010, p. 631.

Leeser DB, Jeevanandam V, Furukawa S, Eisen H, Mather P, Silva P, et al. Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant. 2001;1(1):89-92.

Vossler MR, Ni H, Toy W, Hershberger RE. Preoperative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. J Heart Lung Transplant. 2002;21(8):874-81.

Norman JC, Brook MI, Cooley DA, Klima T, Kahan BD, Frazier OH, et al. Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet. 1978;1(8074):1125-7.

Russo MJ, Rana A, Chen JM, Hong KN, Gelijns A, Moskowitz A, et al. Pretransplantation patient characteristics and survival following combined heart and kidney transplantation: an analysis of the United Network for Organ Sharing Database. Arch Surg. 2009;144(3):241-6.

Narula J, Bennett LE, DiSalvo T, Hosenpud JD, Semigran MJ, Dec GW. Outcomes in recipients of combined heart-kidney transplantation: multiorgan,

same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation. 1997;63(6):861-7.

Blanche C, Valenza M, Czer LS, Barath P, Admon D, Harasty D, et al. Combined heart and kidney transplantation with allografts from the same donor. Ann Thorac Surg. 1994;58(4):1135-8.

Gonwa TA, Husberg BS, Klintmalm GB, Mai ML, Goldstein RM, Capehart JE, et al. Simultaneous heart and kidney transplantation: a report of three cases and review of the literature. J Heart Lung Transplant. 1992;11(1 Pt 1):152-5.

Wang SS, Chou NK, Chi NH, Hsu RB, Huang SC, Chen YS, et al. Simultaneous heart and kidney transplantation for combined cardiac and renal failure. Transplant Proc. 2006;38(7):2135-7.

Odim J, Wheat J, Laks H, Kobashigawa J, Gjertson D, Osugi A, et al. Peri-operative renal function and outcome after orthotopic heart transplantation. J Heart Lung Transplant. 2006;25(2):162-6.

Favaloro R, Peradejordi Lastras M, Bertolotti A, Diez M, Favaloro L, Gomez C, et al. Results of heart transplantation: 16 years’ experience in a center in Argentina. Transplant Proc. 2010;42(1):321-3.

Blanche C, Kamlot A, Blanche DA, Kearney B, Wong AV, Czer LS, et al. Combined heart-kidney transplantation with single-donor allografts. J Thorac Cardiovasc Surg. 2001;122(3):495-500.

Pinderski LJ, Kirklin JK, McGiffin D, Brown R, Naftel DC, Young KR Jr, et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transplant. 2005;24(11):1828-33.

Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol. 2010 Oct;6(10):577-83.

Published
2017-04-24
How to Cite
1.
Peradejordi Lastras M, Favaloro LE, Fortunato RM, Gutiérrez L, Rabin GE, Absi DO, Abud J, Raffaelli H, Marrugat R, Fraguas H, Favaloro RR, Raffaele P, Bertolotti AM. Combined cardiorenal transplant in heart and advanced renal disease. Rev Nefrol Dial Traspl. [Internet]. 2017Apr.24 [cited 2024Nov.25];35(4):188-95. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/40
Issue
Vol. 35 No. 4 (2015): Oct.-Dic.
Section
Original Article